Inventiva (IVA) Receivables (2018 - 2025)
Inventiva (IVA) recorded quarterly Receivables of $2.5 million in Q4 2025, down 99.98% quarter-over-quarter from $12.2 billion in Q2 2025, and up 292.86% on a YoY basis from $627265.5 in Q4 2024.
Inventiva (IVA) Receivables (2018 - 2025) Analysis & Trends
Inventiva's Receivables history runs 8 years deep, the most recent figure standing at $2.5 million for Q4 2025.
- In Q4 2025, Receivables rose 292.86% year-over-year to $2.5 million; the TTM figure through Dec 2025 stood at $2.5 million (up 292.86% YoY), while the FY2025 annual figure was $2.5 million, up 292.86% from the prior year.
- Receivables was $2.5 million for Q4 2025 at Inventiva, down from $12.2 billion in the prior quarter.
- In the past five years, Receivables ranged from a high of $12.2 billion in Q2 2025 to a low of $8429.9 in Q2 2021.
- Historically, Receivables has averaged $1.1 billion across 5 years, with a median of $2.5 million in 2025.
- The sharpest annual moves came in 2022 and 2025: Receivables tumbled 96.64% in 2022, then jumped 178786.64% in 2025.
- A 5-year view of Receivables shows it stood at $4.9 million in 2021, then tumbled by 96.64% to $165280.1 in 2022, then soared by 2661.46% to $4.6 million in 2023, then tumbled by 86.26% to $627265.5 in 2024, then surged by 292.86% to $2.5 million in 2025.
- The last three Receivables figures came in at $2.5 million (Q4 2025), $12.2 billion (Q2 2025), and $627265.5 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 13.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 2.00 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Inventiva | 8.93 Mn | -259.80 Mn | - | 2.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.46 Mn |
| Jun 30, 2025 | 12.18 Bn |
| Dec 31, 2024 | 627,265.50 |
| Jun 30, 2024 | 6.81 Mn |
| Dec 31, 2023 | 4.56 Mn |
| Jun 30, 2023 | 4.29 Mn |
| Dec 31, 2022 | 165,280.07 |
| Jun 30, 2022 | 1.42 Mn |
| Dec 31, 2021 | 4.91 Mn |
| Jun 30, 2021 | 8,429.90 |
| Mar 31, 2021 | 1.55 Mn |
| Dec 31, 2020 | 1.04 Mn |
| Jun 30, 2020 | 1,101.46 |
| Dec 31, 2019 | 711,728.77 |
| Dec 31, 2018 | 969,045.57 |